The Integrated Translational Research has been created within the last cycle ofthe DDRCC, in 2007, as a centralized service aimed to address the needs of an increasing number of translational investigators in the field of digestive diseases at the University of Chicago. It replaces and expands the Clinical Component of the Administrative core, which was limited to assistance for clinical study design and IRB protocols. The Director, Dr. Bana Jabri, together with the Co-PI, Dr. David Rubin, is responsible for ensuring proper scientific direction and efficient use of services. Three main services will be offered: 1) Assistance to design and perform human studies. This service comprises: a) establishment of an """"""""umbrella"""""""" IRB protocol, and help to obtain specific IRBs;b) assistance to design human studies;c) Personal training to perform phenotypic and translational studies on cell purified from intestinal samples;d) Bank of antibodies directed against common human antigens;and e) help for biostatistical analysis in collaboration with the University of Chicago CTSA. 2) Clinical database. This service comprises: a) Obtaining patient consent for clinical data and blood/ tissue acquisition;b) Implementation of a systematic """"""""first visit"""""""" and """"""""follow-up"""""""" clinical questionnaire for patients with inflammatory bowel disease;and c) implementation and maintenance of a longitudinal clinical Velos? database system. Velos eResearch is a highly-regarded clinical research information system chosen by 20 medical institutions with top 25 ratings in U.S. 3) Tissue banking. We are implementing a LIMS (Lab Infonnation Management System) using the caTissue Suite for sample tracking and management. Furthermore, through a collaboration with TRIDOM project ((Translational Research in the Department of Medicine), DDRCC members will have access to DNA, blood and serum samples. Importantly, for DDRCC investigators with the appropriate IRB, it will be possible to match clinical database information with specific biospecimens. The IT core is a central piece ofthe DDRCC that is tightly linked to all other cores ofthe DDRCC. It provides DDRCC investigator with an infrastructure dedicated to integrated translational research in the field of inflammatory intestinal diseases. Patient databases will be integrated with collection of tissue/ DNA/RNA/protein specimens, genotyping, immunological phenotyping, and molecular profiling of patient bacterial microbiomes. This structure will also serve as an umbrella for the training and education of faculty and fellows in unique aspects of patient-oriented research.
The goal of the integrated translational core is to provide an infrastructure that allows to link patient-oriented research and basic science. Establishing this link is critical to advance our understanding of intestinal inflammatory diseases and identify new therapeutic avenues.
|Cockrell, Chase; An, Gary (2017) Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model. J Theor Biol 430:157-168|
|Pekow, Joel; Meckel, Katherine; Dougherty, Urszula et al. (2017) miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res 23:5281-5291|
|Messer, Jeannette S (2017) The cellular autophagy/apoptosis checkpoint during inflammation. Cell Mol Life Sci 74:1281-1296|
|An, G; Fitzpatrick, B G; Christley, S et al. (2017) Optimization and Control of Agent-Based Models in Biology: A Perspective. Bull Math Biol 79:63-87|
|Arvans, Donna; Jung, Yong-Chul; Antonopoulos, Dionysios et al. (2017) Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J Am Soc Nephrol 28:876-887|
|Nobutani, Kentaro; Miyoshi, Jun; Musch, Mark W et al. (2017) Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal. Pharmacol Res Perspect 5:|
|Messer, J S; Liechty, E R; Vogel, O A et al. (2017) Evolutionary and ecological forces that shape the bacterial communities of the human gut. Mucosal Immunol 10:567-579|
|Nie, Litong; Shuai, Lin; Zhu, Mingrui et al. (2017) The Landscape of Histone Modifications in a High-Fat Diet-Induced Obese (DIO) Mouse Model. Mol Cell Proteomics 16:1324-1334|
|Denzin, Lisa K; Khan, Aly A; Virdis, Francesca et al. (2017) Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity 47:310-322.e7|
|Alverdy, John C; Luo, James N (2017) The Influence of Host Stress on the Mechanism of Infection: Lost Microbiomes, Emergent Pathobiomes, and the Role of Interkingdom Signaling. Front Microbiol 8:322|
Showing the most recent 10 out of 633 publications